Stephen Landy

Summary

Publications

  1. ncbi request reprint Migraine treatment throughout the lifecycle
    Stephen H Landy
    University of Tennessee College of Medicine, Department of Neurology, 8000 Centerview Parkway, Suite 101, Memphis, TN, USA
    Expert Rev Neurother 5:343-53. 2005
  2. ncbi request reprint Central sensitisation and cutaneous allodynia in migraine: implications for treatment
    Stephen Landy
    Wesley Headache Clinic and University of Tennessee Medical School, Memphis, Tennessee, USA
    CNS Drugs 18:337-42. 2004
  3. ncbi request reprint Challenging or difficult headache patients
    Stephen H Landy
    Wesley Headache Clinic, 8974 Bridge Forest Drive, Memphis, TN 38138, USA
    Prim Care 31:429-40, viii. 2004
  4. pmc Fixed-dose Sumatriptan/Naproxen Sodium Compared with each Monotherapy Utilizing the Novel Composite Endpoint of Sustained Pain-free/no Adverse Events
    Stephen Landy
    Wesley Headache Clinic, Memphis, TN, USA
    Ther Adv Neurol Disord 2:135-41. 2009
  5. ncbi request reprint Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine
    S Landy
    Wesley Headache and Neurology Clinic, 8000 Centerview Parkway, Suite 101, Memphis, TN 38018, USA
    Int J Clin Pract 58:913-9. 2004
  6. pmc Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes
    Stephen Landy
    Wesley Neurology Clinic, Memphis, Tennessee, USA
    MedGenMed 9:53. 2007
  7. ncbi request reprint Migraine: a better way to recognize and treat it
    Stephen H Landy
    Wesley Headache Clinic, 8974 Bridge Forest Drive, Memphis, TN 38138, USA
    J Fam Pract 55:1038-47. 2006
  8. doi request reprint Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention
    Stephen Landy
    Wesley Headache Clinic, University of Tennessee Medical School, Memphis, TN, USA
    Headache 52:133-9. 2012
  9. doi request reprint Time to recovery in patients with acute painful musculoskeletal conditions treated with extended-release or immediate-release cyclobenzaprine
    Stephen Landy
    Department of Neurology, University of Tennessee Health Science Center, Memphis, USA
    Adv Ther 28:295-303. 2011
  10. ncbi request reprint Migraine throughout the life cycle: treatment through the ages
    Stephen Landy
    Wesley Headache Clinic, Memphis, TN 38138, USA
    Neurology 62:S2-8. 2004

Detail Information

Publications14

  1. ncbi request reprint Migraine treatment throughout the lifecycle
    Stephen H Landy
    University of Tennessee College of Medicine, Department of Neurology, 8000 Centerview Parkway, Suite 101, Memphis, TN, USA
    Expert Rev Neurother 5:343-53. 2005
    ..Lastly, the current optimal treatment of migraine is provided and the potential role of calcitonin gene-related peptide antagonists in the future is discussed...
  2. ncbi request reprint Central sensitisation and cutaneous allodynia in migraine: implications for treatment
    Stephen Landy
    Wesley Headache Clinic and University of Tennessee Medical School, Memphis, Tennessee, USA
    CNS Drugs 18:337-42. 2004
    ..Therefore, in the subset of patients who report symptoms of cutaneous allodynia with migraine attacks, early initiation of triptan therapy is currently the best intervention to achieve rapid, complete and sustained pain relief...
  3. ncbi request reprint Challenging or difficult headache patients
    Stephen H Landy
    Wesley Headache Clinic, 8974 Bridge Forest Drive, Memphis, TN 38138, USA
    Prim Care 31:429-40, viii. 2004
    ....
  4. pmc Fixed-dose Sumatriptan/Naproxen Sodium Compared with each Monotherapy Utilizing the Novel Composite Endpoint of Sustained Pain-free/no Adverse Events
    Stephen Landy
    Wesley Headache Clinic, Memphis, TN, USA
    Ther Adv Neurol Disord 2:135-41. 2009
    ....
  5. ncbi request reprint Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine
    S Landy
    Wesley Headache and Neurology Clinic, 8000 Centerview Parkway, Suite 101, Memphis, TN 38018, USA
    Int J Clin Pract 58:913-9. 2004
    ....
  6. pmc Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes
    Stephen Landy
    Wesley Neurology Clinic, Memphis, Tennessee, USA
    MedGenMed 9:53. 2007
    ....
  7. ncbi request reprint Migraine: a better way to recognize and treat it
    Stephen H Landy
    Wesley Headache Clinic, 8974 Bridge Forest Drive, Memphis, TN 38138, USA
    J Fam Pract 55:1038-47. 2006
    ..Use the quiz also to better understand the impact of migraine on a patient's life, and to help determine which patients need migraine-specific therapy...
  8. doi request reprint Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention
    Stephen Landy
    Wesley Headache Clinic, University of Tennessee Medical School, Memphis, TN, USA
    Headache 52:133-9. 2012
    ....
  9. doi request reprint Time to recovery in patients with acute painful musculoskeletal conditions treated with extended-release or immediate-release cyclobenzaprine
    Stephen Landy
    Department of Neurology, University of Tennessee Health Science Center, Memphis, USA
    Adv Ther 28:295-303. 2011
    ..Frazer, PA, USA), cyclobenzaprine immediate release (CIR; Flexeril(®), Pliva, Pomona, NY, USA), or placebo administration...
  10. ncbi request reprint Migraine throughout the life cycle: treatment through the ages
    Stephen Landy
    Wesley Headache Clinic, Memphis, TN 38138, USA
    Neurology 62:S2-8. 2004
    ..Clinicians who treat migraine must be aware of considerations specific to children, women, and the elderly...
  11. ncbi request reprint Selective serotonin reuptake inhibitors for migraine prophylaxis
    S Landy
    Wesley Headache and Neurology Clinic, University of Tennessee, Memphis, TN 38138, USA
    Headache 39:28-32. 1999
    ....
  12. ncbi request reprint Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan
    Stephen H Landy
    Wesley Headache and Neurology Clinic, Memphis, TN 38018, USA
    Headache 45:346-9. 2005
    ..Subcutaneous sumatriptan (6 mg) is undeniably an excellent treatment of migraine. However, some patients have avoided using 6 mg sumatriptan because of unpleasant or unwanted side effects...
  13. ncbi request reprint Clarification of developing and established clinical allodynia and pain-free outcomes
    Stephen H Landy
    Wesley Headache Clinic, Memphis, TN 38018, USA
    Headache 47:247-52. 2007
    ..The aim of this study was to determine whether clinical indicators of cutaneous allodynia predict the success of migraine therapy with sumatriptan using a brief questionnaire...
  14. ncbi request reprint Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series
    Stephen H Landy
    Wesley Headache Clinic, Memphis, TN 38018, USA
    Headache 44:762-6. 2004
    ..Oral transmucosal fentanyl citrate (OTFC; ACTIQ) is a novel opioid product designed to deliver rapid analgesia to patients who experience breakthrough pain (BTP)...